APA

You Q., Jiang C., Wu Y., Yu X., Chen Y., Zhang X., Wei W., Wang Y., Tang Z., Jiang D., Wu Y., Wang C., Meng X., Zhao X. & Kong W. (20120216). Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis. : Scandinavian journal of immunology.

Chicago

You Q, Jiang C, Wu Y, Yu X, Chen Y, Zhang X, Wei W, Wang Y, Tang Z, Jiang D, Wu Y, Wang C, Meng X, Zhao X and Kong W. 20120216. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis. : Scandinavian journal of immunology.

Harvard

You Q., Jiang C., Wu Y., Yu X., Chen Y., Zhang X., Wei W., Wang Y., Tang Z., Jiang D., Wu Y., Wang C., Meng X., Zhao X. and Kong W. (20120216). Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis. : Scandinavian journal of immunology.

MLA

You Q, Jiang C, Wu Y, Yu X, Chen Y, Zhang X, Wei W, Wang Y, Tang Z, Jiang D, Wu Y, Wang C, Meng X, Zhao X and Kong W. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis. : Scandinavian journal of immunology. 20120216.